A Global Tour of Options for Scaling-Up HCV Testing to Reach Elimination Goals
What testing platforms are used? If required, how are specimens transferred to the laboratory? How long does it take for patients to get results? How are patients linked to care?
This webinar will explore the "how to" of implementing HCV testing programs, diving into the details of how testing programs work. Speakers from Egypt, Georgia, Rwanda, Viet Nam, and Mexico will present on diverse testing program models, including a) point-of-care antibody testing/laboratory-based PCR testing, b) laboratory-based antibody/PCR testing, and c) point-of-care antibody/PCR testing. Presenters will share the nuts and bolts of how these different strategies are operationalized and will also discuss the effectiveness of the program, financing and costs, and next steps for improvement or expansion.
Speakers and discussants include:
*Egypt National HCV Program
Dr. Mohamed Hassany, National Hepatology and Tropical Medicine Research Institute
*Georgia National HCV Program
Dr. Maia Alkhazashvili, Lugar Center, National Center for Disease Control and Public Health
*Rwanda National HCV Program
Dr. Janvier Serumondo and Dr. Makuza Jean Damascene, Rwanda Biomedical Center
*Ho Chi Minh City CHIME Program
Dr. Doan Do, Viet Nam Viral Hepatitis Alliance
*Mexico National HCV Elimination Program
Dr. David Kershenobich, Director General, National Institute of Medical Sciences and Nutrition “Salvador Zubirán” (INCMNSZ)